By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Hadasit Bio-Holdings Ltd (HSITF)

OTC Market Data in USD, Fundamentals in ILS
$1.59
+$1.47
+1.23K%
Last Update: 29 Aug 2025, 00:00
$17.63M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.12 - $1.59
52 Week Range

HSITF Stock Price Chart

Explore Hadasit Bio-Holdings Ltd interactive price chart. Choose custom timeframes to analyze HSITF price movements and trends.

HSITF Company Profile

Discover essential business fundamentals and corporate details for Hadasit Bio-Holdings Ltd (HSITF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

27 Oct 2010

Employees

2.00

CEO

Yoram Azulai

Description

Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.

HSITF Financial Timeline

Browse a chronological timeline of Hadasit Bio-Holdings Ltd corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

HSITF Stock Performance

Access detailed HSITF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run